Are you looking quote for part CAFERGOT SUPP. 5X2MG? The Novartis Pharmaceuticals Ltd-manufactured component (CAGE Code: B1049) is documented under NSN 6505-01-457-8137 as Ergotamine Tartrate. For the fastest quote, please complete our RFQ form with details about CAFERGOT SUPP. 5X2MG. We guarantee a response within 15 minutes.
ASAP Components provides the verified CAFERGOT SUPP. 5X2MG, classified under INC 34182, FSG , FSC , NIIN 01-457-8137, and NCB 01. Submit your requirements today to receive immediate pricing and availability information.
| MRC | Criteria | Characteristic |
|---|---|---|
| FEAT | SPECIAL FEATURES | USED IN TREATING MIGRAINE HEADACHES; SYMPATHOLYTIC DRUG; ADMINISTERED IN SUPPOSITORY FORM; 5 SUPPOSITORIES PR PKG; 1 SUPP PR WRAPPER; NON HABIT FORMING; CONSTRICTS BLOOD VESSELS IN HEAD; STIMULATES CENTRAL NERVOUS SYSTEM; NOT INTENDED FOR P |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 2.000 MILLIGRAMS ERGOTAMINE TARTRATE ACTIVE INGREDIENT AND 100.000 MILLIGRAMS CAFFEINE ACTIVE INGREDIENT |
| End Use : 40100 | Pharmaceutical preparations |
|---|---|
| Schedule B : 3004400070 (NAICS 325412) | Other medicaments containing alkaloids or derivatives thereof but notcontaining hormones, other products of head 2937 or antibiotics, nes oi |
| SITC : 54232 | Medicaments containing alkaloids and their derivatives, n.E.S., in dosage form or retail packings |
| ADPE | Represents items with no adp components |
|---|---|
| CRITL | The item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. |
| ESD | A - No known electrostatic discharge (esd) or electromagnetic interference (emi) sensitivity. |
| HMIC | P - Indicates there is no information in the hmirs. The nsn is in a fsc in table ii of federal standard 313 and a msds may be required by the user. The requirement for a msds is dependent on a hazard determination of the supplier or the intended end use of item. |
| PMIC | A - Item does not contain precious metal. |
